cluster-of-differentiation antigen; cluster designation antigen; CD antigen

Specific

CD1 CD2; T-cell surface antigen CD2; T-cell surface antigen T11/Leu-5; LFA-2; LFA-3 receptor; erythrocyte receptor; rosette receptor (SRBC) CD3 CD4; T-cell surface glycoprotein CD4; T-cell surface antigen T4/Leu-3 CD5; T-cell surface glycoprotein CD5; lymphocyte antigen T1/Leu-1 (CD5, LEU1) CD6; T-cell differentiation antigen CD6; T12; TP120 CD7; T-cell antigen CD7; GP40; T-cell leukemia antigen; TP41 CD8 CD9; p24; leukocyte antigen MIC3; Motility-related protein; MRP-1; tetraspanin-29; Tspan-29; 5H9 antigen; cell growth-inhibiting gene 2 protein (MIC3, TSPAN29, GIG2) CD10 (neprilysin, neutral endopeptidase, enkephalinase, common acute lymphoblastic leukemia antigen, CALLA, atriopeptidase, MME, EPN) CD11 CD12 or CDw12 CD13; aminopeptidase-N; aminopeptidase-M; gp150; microsomal aminopeptidase; alanine aminopeptidase (ANPEP, PEPN) CD14; monocyte differentiation antigen CD14; myeloid cell-specific leucine-rich glycoprotein CD15, Lewis X or X-hapten CD16, Fc gamma receptor III or Fc gamma receptor (low affinity) CD17 or lactosylceramide CD18 (integrin beta-2, L-CAM beta, ITGB2, CD18, MFI7) CD19; B-lymphocyte antigen CD19; differentiation antigen CD19; B-lymphocyte surface antigen B4; Leu-12 CD20; B-lymphocyte antigen CD20; membrane-spanning 4-domains subfamily A member 1; B-lymphocyte surface antigen B1; Leu-16; Bp35 (MS4A1) CD21; complement receptor type 2; Cr2; complement C3d receptor; Epstein-Barr virus receptor; EBV receptor (CR2, C3DR) CD22; B-cell receptor CD22; sialic acid-binding Ig-like lectin 2; siglec-2; Leu-14; B-lymphocyte cell adhesion molecule; BL-CAM (IGLEC2) CD23; low affinity immunoglobulin epsilon Fc receptor; lymphocyte IgE receptor; Fc-epsilon-RII; BLAST-2; immunoglobulin E-binding factor (FCER2, CD23A, FCE2, IGEBF) CD24; signal transducer CD24; small cell lung carcinoma cluster 4 antigen (CD24, CD24A) CD25; interleukin-2 receptor alpha chain; IL-2 receptor alpha subunit; IL-2-RA; IL2-RA; p55; TAC antigen (IL2RA) CD26; dipeptidyl peptidase 4; dipeptidyl peptidase IV; DPP IV; T-cell activation antigen CD26; TP103; adenosine deaminase (ADA) complexing protein 2; ADABP (DPP4, ADCP2) CDw26; T-cell activation antigen CD27, CD27L receptor, TNF receptor family, member 7 (TNFRSF7) or T-cell activation antigen T4 CD28; T-cell-specific surface glycoprotein CD28; TP44 CD29; integrin-beta 1; fibronectin receptor beta; platelet glycoprotein IIa; VLA-4 beta (ITGB1, FNRB, MDF2, MSK12) CD30; tumor necrosis factor receptor superfamily member 8; CD30L receptor; lymphocyte activation antigen CD30; KI-1 antigen (TNFRSF8, D1S166E) CD31; platelet endothelial cell adhesion molecule; PECAM-1; endoCAM; GPIIA (PECAM1) CD32 or Fc gamma [IgG] receptor-II (low affinity) CD33; myeloid cell surface antigen CD33; sialic acid-binding Ig-like lectin 3; siglec-3; gp67 (SIGLEC3) CD34; hematopoietic progenitor cell antigen CD34 (CD34) CD35, complement component (3b/4b) receptor-1, C3b-1/Epstein Barr Virus [EBV] receptor or C4-binding protein CD36; platelet glycoprotein 4; platelet glycoprotein IV; GPIV; glycoprotein IIIb; GPIIIB; leukocyte differentiation antigen CD36; PAS IV; PAS-4; platelet collagen receptor; fatty acid translocase; FAT; Thrombospondin receptor (GP3B, GP4) CD37 (cell surface glycoprotein CD37, leukocyte antigen CD37, tetraspanin-26, Tspan-26) CD38; ADP-ribosyl cyclase 1; cyclic ADP-ribose hydrolase 1; cADPr hydrolase 1; T10 CD39; ectonucleoside triphosphate diphosphohydrolase 1; NTPDase 1; ecto-ATP diphosphohydrolase; ATPDase; lymphoid cell activation antigen; ecto-apyrase (ENTPD1) CD40 [CDw40], TNF receptor family member 5 (TNFRSF5), Bp50 or B-cell activation protein CD40 CD41; integrin alpha-IIb; platelet membrane glycoprotein IIb (ITGA2B, GP2B, ITGAB) CD42 CD43; leukosialin; leukocyte sialoglycoprotein; sialophorin; galactoglycoprotein; GALGP (SPN) CD44; phagocytic glycoprotein I; PGP-1; HUTCH-I; extracellular matrix receptor-III; ECMR-III; GP90 lymphocyte homing/adhesion receptor; Hermes antigen; hyaluronate receptor; heparan sulfate proteoglycan; epican; CDw44 (LHR, MDU2, MDU3, MIC4) CD45 (leukocyte common antigen T200 or protein tyrosine phosphatase, receptor type, C polypeptide) CD46, trophoblast leukocyte common antigen, membrane cofactor protein (MCP), TLX, MIC10 CD47; leukocyte surface antigen CD47; integrin-associated protein; IAP; antigenic surface determinant protein OA3; protein MER6 (CD47, MER6) CD47R, CDw149 or Rh related antigen CD48; B-lymphocyte activation marker BLAST-1; BCM1 surface antigen; Leukocyte antigen MEM-102; TCT.1 (BCM1, BLAST1) CD49 or Very Late Antigen (VLA) CD49a; integrin alpha-1; CD49 antigen-like family member A; laminin & collagen receptor; VLA-1 (ITGA1) CD49b (integrin alpha-2, VLA-2 alpha chain or platelet membrane glycoprotein IA, ITGA2) CD49c (integrin-alpha 3, VLA-3 alpha chain, galactoprotein-B3, GAPB3, ITGA3) CD49d (integrin alpha-4, VLA-4 alpha chain, ITGA4) CD49e (integrin alpha-5, integrin alpha-F, fibronection receptor alpha subunit, ITGA5) CD49f (integrin alpha-6, integrin alpha-F, ITGA6) CD50; intercellular adhesion molecule 3; ICAM-3; ICAM-R; CDw50 (ICAM3) CD51 (integrin alpha-V, vitronectin receptor alpha chain, ITGAV, MSK8, VNRA) CD52; CAMPATH-1 antigen; Cambridge pathology 1 antigen; epididymal secretory protein E5; CDw52 (CDW52, HE5) CD53; leukocyte surface antigen CD53; cell surface glycoprotein CD53; tetraspanin-25; Tspan-25 (MOX44, TSPAN25) CD54; intercellular adhesion molecule 1; ICAM-1; major group rhinovirus receptor (ICAM1) CD55; complement decay accelerating factor (DAF) CD56; neural cell adhesion molecule 1; NCAM-1 (NCAM1, NCAM) CD57 antigen (LEU7) CD58; lymphocyte function-associated antigen 3; Ag3; Surface glycoprotein LFA-3 (LFA3) CD59; CD59 glycoprotein; membrane attack complex inhibition factor; MACIF; MAC-inhibitory protein; MAC-IP; protectin; MEM43 antigen; membrane inhibitor of reactive lysis; MIRL; 20 kD homologous restriction factor; HRF-20; HRF20; 1F5 antigen (MIC11, MIN1, MIN2, MIN3, MSK21) CDw60 CD61 (integrin-beta 3, platelet membrane glycoprotein IIIA, GPIIIA, ITGB3, GP3A) CD62E, E-selectin; endothelial leukocyte adhesion molecule 1; ELAM-1; leukocyte-endothelial cell adhesion molecule 2; LECAM2; CD62 antigen-like family member E (SELE, ELAM1) CD62L, L-selectin; lymph node homing receptor; Leukocyte adhesion molecule 1; LAM-1; Leukocyte surface antigen Leu-8; TQ1; Mel-14; gp90-MEL; Leukocyte-endothelial cell adhesion molecule 1; LECAM1; CD62 antigen-like family member L (SELL, LNHR, LYAM1) CD62P, P-selectin; granule membrane protein 140; GMP-140; PADGEM; leukocyte-endothelial cell adhesion molecule 3; LECAM3; CD62 antigen-like family member P (SELP, GMRP, GRMP) CD63; granulophysin; tetraspanin-30; Tspan-30; melanoma-associated antigen ME491; platelet activation antigen Pltgp40; ocular melanoma-associated antigen OMA81H; lysosome-associated membrane glycoprotein-3; lamp-3; antigen AD1 (NKI/C3) CD64; high affinity immunoglobulin gamma Fc receptor I; IgG Fc receptor I; Fc-gamma RI; FcRI (FCGR1A, FCG1, FCGR1, IGFR1) CD65 or ceramide-dodecasaccharide CD66a; carcinoembryonic antigen-related cell adhesion molecule 1; biliary glycoprotein 1; BGP-1 (CEACAM1, BGP, BGP1) CD66b; carcinoembryonic antigen-related cell adhesion molecule 8; carcinoembryonic antigen CGM6; non-specific cross-reacting antigen NCA-95; CD67 antigen (CEACAM8, CGM6) CD66c; carcinoembryonic antigen-related cell adhesion molecule 6; normal cross-reacting antigen; non-specific crossreacting antigen (CEACAM6 NCA) CD66D; carcinoembryonic antigen-related cell adhesion molecule 3; carcinoembryonic antigen CGM1 (CEACAM3, CD66D, CGM1) CD66e; carcinoembryonic antigen-related cell adhesion molecule 5; carcinoembryonic antigen; CEA; meconium antigen 100; CD66e (CEACAM5, CEA) CD66f; pregnancy-specific beta-1-glycoprotein 1; PS-beta-G-1; PSBG-1; pregnancy-specific glycoprotein 1; CD66 antigen-like family member F; fetal liver non-specific cross-reactive antigen 1/2; FL-NCA-1/2; PSG95; pregnancy-specific beta-1 glycoprotein C/D; PS-beta-C/D (PSG1, B1G1, PSBG1, PSGGA) CD68; macrosialin; Gp110 (CD68) CD69; early activation antigen CD69; early T-cell activation antigen p60; GP32/28; Leu-23; MLR-3; EA1; BL-AC/P26; activation inducer molecule; AIM (CD69) CD70 antigen; CD27 ligand; CD27-L; tumor necrosis factor ligand superfamily member 7 (CD70, CD27L, CD27LG, TNFSF7) CD71; transferrin receptor 1; TfR1; TfR; TR; Trfr; T9; p90; sTfR (TFRC) CD72; B-cell differentiation antigen CD72; Lyb-2 (CD72) CD73 (ecto-5'nucleotidase, 5-prime-ribonucleotide phosphohydrolase, NT5E) CD74; HLA class II histocompatibility antigen gamma chain; HLA-DR antigens-associated invariant chain; Ia antigen-associated invariant chain; Ii; p33 (DHLAG) CD75 antigen; lactosamine CD77, globotriaosylceramide, pK blood group antigen or burkitt's lymphoma antigen BLA CD79 or B-cell antigen receptor complex-associated protein CD80, antigen-presenting cell B7-1, B-lymphocyte activation antigen B7-1, or BB1 CD81 antigen; 26 kD cell surface protein TAPA-1; target of the antiproliferative antibody 1; tetraspanin-28; Tspan-28 (CD81, TAPA1, TSPAN28) CD82 (metastasis suppressor Kangai 1, KAI1, C33 antigen, IA4, inducible membrane protein R2, tetraspanin-27, Tspan-27) CD83 antigen; cell surface protein HB15; B-cell activation protein (CD83) CD84 leukocyte antigen; SLAM family member 5 precursor; signaling lymphocytic activation molecule 5; cell surface antigen MAX.3; Hly9-beta (SLAMF5) CD85 or leukocyte immunoglobulin-like receptor family protein CD86, activation B7-2 antigen, B70, fun-1 or BU63 CD88; C5a anaphylatoxin chemotactic receptor; C5a-R; C5aR (C5AR1, C5AR, C5R1) CD89; immunoglobulin alpha Fc receptor; IgA Fc receptor (FCAR) CD90; thy-1 membrane glycoprotein; thy-1 antigen; CDw90 (THY1) CD91, low density lipoprotein (LDL) receptor related protein (LRP) 1, apolipoprotein E [apoE] receptor 1, chylomicron remnant receptor or alpha-2 macroglobulin receptor CDw92 (choline transporter like 1, Solute carrier family 44 member 1, SLC44A1, CTL1, CD92) CD93; complement component C1q receptor; complement component 1 q subcomponent receptor 1; C1q/MBL/SPA receptor; C1qR(p); C1qRp; C1qR; matrix-remodeling-associated protein 4; CDw93; collectin receptor (CC1QR1, MXRA4) CD94; killer cell lectin-like receptor D1; natural killer cells antigen CD94 (KLRD1) CD95; Fas antigen; tumor necrosis factor receptor superfamily member 6; apo-1 antigen; apoptosis-mediating surface antigen FAS; FASLG receptor (FAS, APT1, FAS1, TNFRSF6) CD96; T-cell surface protein tactile; T cell-activated increased late expression protein; cell surface antigen CD96 CD97 antigen; Leukocyte antigen CD97; CD97; contains CD97 antigen subunit alpha & CD97 antigen subunit beta (CD97) CD98; solute carrier family 3A2; 4F2 cell-surface antigen heavy chain; 4F2hc; lymphocyte activation antigen 4F2 large subunit; 4F2 heavy chain antigen (SLC3A2, MDU1) CD99; T-cell surface glycoprotein E2; E2 antigen; protein MIC2; 12E7 (CD99, MIC2, MIC2X, MIC2Y) CD100; semaphorin-4D; BB18; A8; GR3 (SEMA4D, CD100, SEMAJ) CD101; immunoglobulin superfamily member 2; Glu-Trp-Ile EWI motif-containing protein 101; EWI-101; cell surface glycoprotein V7 (CD101, EWI101, IGSF2, V7) CD102; intercellular adhesion molecule 2; ICAM-2 (ICAM2) CD103 (integrin alpha-E, mucosal lymphocyte-1 antigen, HML-1 antigen, human mucosal lymphocyte antigen 1 antigen, ITGAE) CD104 (integrin-beta 4, GP150, ITGB4) CD105 or endoglin CD106; vascular cell adhesion protein 1; V-CAM 1; INCAM-100 (VCAM1, L1CAM) CD107a; CD107 antigen-like family member A; lysosome-associated membrane glycoprotein 1; LAMP-1 (LAMP1) CD107b; CD107 antigen-like family member B; lysosome-associated membrane glycoprotein 2; LAMP-2 (LAMP2) CD108; semaphorin-7A; semaphorin-L; sema L; semaphorin-K1; sema K1; John-Milton-Hargen human blood group Ag; JMH blood group antigen; CDw108 (SEMA7A, CD108, SEMAL) CD109 antigen; C3 & PZP-like alpha-2-macroglobulin domain-containing protein 7; 150 kD TGF-beta-1-binding protein; platelet-specific Gov antigen; human platelet antigen 15; HPA-15; p180; r150 (CD109, CPAMD7) CD110; thrombopoietin receptor; TPO-R; myeloproliferative leukemia protein; C-mpl (MPL, TPOR) CD110; thrombopoietin receptor; TPO-R; myeloproliferative leukemia protein; C-mpl (MPL, TPOR) CD111; poliovirus receptor-related protein 1; Herpes virus entry mediator C; Herpesvirus entry mediator C; HveC; Herpesvirus Ig-like receptor; HIgR; nectin-1 (PVRL1, HVEC, PRR1) CD112; poliovirus receptor-related protein 2; Herpes virus entry mediator B; nectin 2 (PVRL2, HVEB, PRR2) CDw113 (poliovirus receptor-related protein 3, nectin-3, CD113 antigen, PVRL3, PRR3) CD114, colony stimulating factor 3 receptor or granulocyte colony-stimulating factor [G-CSF] receptor CD115; macrophage colony-stimulating factor 1 receptor; CSF-1 receptor; CSF-1-R; CSF-1R; M-CSF-R; proto-oncogene c-Fms (CSF1R, FMS) CDw116; granulocyte-macrophage colony-stimulating factor receptor subunit alpha; GM-CSF receptor-alpha; GM-CSF-R-alpha; GMR;CD116 (CSF2RA, CSF2R, CSF2RY) CD117; c-kit protein; mast/stem cell growth factor receptor; SCFR; proto-oncogene tyrosine-protein kinase Kit; c-kit (KIT) CD118; leukemia inhibitory factor [LIF] receptor alpha, LIF binding protein; LIF receptor alpha; LIF-R (LIFR, LIFRA) CDw119; interferon-gamma receptor alpha chain; IFN-gamma-R1; CD119 (IFNGR1) CD120a; TNF receptor-1A; tumor necrosis factor receptor superfamily member 1A; p60; TNF-R1; TNF-RI; TNFR-I; p55;; TBPI (TNFRSF1A, TNFAR, TNFR1) CD120b; tumor necrosis factor receptor superfamily member 1B; tumor necrosis factor receptor 2; TNF-R2; tumor necrosis factor receptor type II; p75; p80 TNF-alpha receptor; p75TNF receptor; TBPII; TBP-2 (TNFRSF1B, TNFBR, TNFR2) CDw121A, interleukin-1 receptor type I; IL-1R-1; IL-1RT1; IL-1R-alpha; p80; CD121 antigen-like family member A; CD121a (IL1R1, IL1RA, IL1RT1) CDw121b; interleukin-1 receptor type II; IL-1R-2; IL-1R-beta; CD121 antigen-like family member B; CDw121b; CD121b antigen; CD121 (IL1R2, IL1RB) CD122; interleukin-2 receptor subunit beta; IL-2 receptor beta; P70-75; p75 (IL2RB) CD123; interleukin-3 receptor subunit alpha; IL-3R-alpha (IL3RA, IL3R) CD124; interleukin-4 receptor alpha chain; IL-4R-alpha; sIL4Ralpha/prot; IL-4-binding protein; IL4-BP (IL4R, 582J21, IL4RA) CD125; interleukin-5 receptor subunit alpha; IL-5R-alpha; CDw125; CD125 (IL5RA, IL5R) CD126; interleukin-6 receptor subunit alpha; IL-6R-alpha; IL-6R 1; membrane glycoprotein 80; gp80 (IL6R) CD127; CDw127; interleukin-7 [IL-7] receptor-alpha (IL7RA, IL7R) CD128 CD129; interleukin-9 receptor (IL9 receptor) CD130; gp130; interleukin-6 receptor subunit beta; IL-6R-beta; interleukin-6 signal transducer; membrane glycoprotein 130; CDw130; oncostatin-M receptor alpha subunit (IL6ST) CDw131; cytokine receptor common subunit beta; KH97; GM-CSF/IL-3/IL-5 receptor common beta-chain; CDw131; CD131 (CSF2RB, IL3RB, IL5RB) CD132; cytokine receptor common gamma chain; gamma-C; interleukin-2 receptor gamma chain; IL-2R gamma chain; p64 (IL2RG) CD133; prominin-1; antigen AC133; prominin-like protein 1 (PROM1, PROML1, MSTP061) CD134; tumor necrosis factor receptor superfamily member 4; OX40L receptor; ACT35 antigen; TAX transcriptionally-activated glycoprotein 1 receptor (TNFRSF4, TXGP1L) CD135; FL cytokine receptor; tyrosine-protein kinase receptor FLT3; stem cell tyrosine kinase 1; STK-1;(FLT3, STK1) CD136; macrophage-stimulating protein receptor; MSP receptor; p185-Ron; CDw136 (MST1R, PTK8, RON) CD137; tumor necrosis factor receptor superfamily member 9; 4-1BB ligand receptor; T-cell antigen 4-1BB homolog; T-cell antigen ILA; CDw137 (TNFRSF9, CD137, ILA) CD138; syndecan-1; SYND1 (SDC1, SDC) CD140a; PDGF-R-alpha; alpha-type platelet-derived growth factor receptor; CD140 antigen-like family member A; CD140a antigen (PDGFRA) CD142; thromboplastin; tissue factor; TF; coagulation factor III (F3) CD146; cell surface glycoprotein MUC18; melanoma-associated antigen MUC18; melanoma cell adhesion molecule; melanoma-associated antigen A32; S-endo 1 endothelial-associated antigen; cell surface glycoprotein P1H12 (MCAM, MUC18) CD147; basigin; leukocyte activation antigen M6; collagenase stimulatory factor; extracellular matrix metalloproteinase inducer; EMMPRIN; 5F7; tumor cell-derived collagenase stimulatory factor; TCSF; OK blood group antigen (BSG) CD148; receptor-type tyrosine-protein phosphatase eta; protein-tyrosine phosphatase eta; R-PTP-eta; density-enhanced phosphatase 1; DEP-1; HPTP eta; protein-tyrosine phosphatase receptor type J; R-PTP-J (PTPRJ, DEP1) CD150; signaling lymphocytic activation molecule; CDw150; IPO-3 (SLAMF1, SLAM) CD151; platelet-endothelial tetraspan antigen 3; PETA-3; GP27; membrane glycoprotein SFA-1; tetraspanin-24; Tspan-24; CD151 antigen (CD151, TSPAN24) CD152 (cytotoxic T-cell protein 4-1, cytotoxic T lymphocyte-associated serine esterase-4, CTLA-4, CD152 antigen, CTLA4, CD152) CD153; tumor necrosis factor ligand superfamily member 8; CD30 ligand; CD30-L (TNFSF8, CD30L, CD30LG) CD154; CD40 ligand; CD40-L; T-cell antigen Gp39; TNF-related activation protein; TRAP; tumor necrosis factor ligand superfamily member 5 (CD40LG, CD40L TNFSF5, TRAP) CD155; poliovirus receptor; nectin-like protein 5; necl-5 (PVR, PVS) CD156; cell surface antigen MS2; a disintegrin & metalloproteinase domain 8 (ADAM8) CD156b, A disintegrin & metalloproteinase domain 17; TNF-alpha-converting enzyme; TNF-alpha convertase; snake venom-like protease; CD156b (ADAM17, CSVP, TACE) CD156c; CDw156; A disintegrin & metalloproteinase domain 10; Kuzbanian protein homolog; mammalian disintegrin-metalloprotease (ADAM10, KUZ, MADM) CD157; ADP-ribosyl cyclase 2; cyclic ADP-ribose hydrolase 2; bone marrow stromal antigen 1 (BST1) CD158 CD158c; killer cell immunoglobulin-like receptor like protein KIR3DP1 (KIR3DP1, CD158C, KIR2DS6, KIR48, KIRX) CD159a; NKG2-A/NKG2-B type II integral membrane protein; NKG2-A/B-activating NK receptor; NK cell receptor A; CD159 antigen-like family member A; killer cell lectin-lik receptor subfamily C member 1 (KLRC1, NKG2A) CD159c; NKG2-C type II integral membrane protein; NKG2-C-activating NK receptor; NK cell receptor C; CD159 antigen-like family member C (KLRC2, NKG2C) CD160 antigen; natural killer cell receptor BY55 (CD160, BY55) CD161; killer cell lectin-like receptor subfamily B member 1; natural killer cell surface protein P1A; HNKR-P1a; NKR-P1A; C-type lectin domain family 5 member B (KLRB1, CLEC5B, NKRP1A) CD162; P-selectin glycoprotein ligand 1; PSGL-1; selectin P ligand (SELPLG) CD163 antigen (scavenger receptor cysteine-rich type 1 protein M130, hemoglobin scavenger receptor, M130) CD163B (scavenger receptor cysteine-rich type 1 protein M160, CD163 antigen-like 1, CD163b antigen, CD163L1, M160, UNQ6434/PRO23202) CD164; sialomucin core protein 24; MUC-24; endolyn; multi-glycosylated core protein 24; MGC-24; MGC-24v (CD164) CD166 antigen; activated leukocyte cell adhesion molecule; CD166 (ALCAM, MEMD) CD167a; epithelial discoidin domain-containing receptor 1; epithelial discoidin domain receptor 1; tyrosine kinase DDR; discoidin receptor tyrosine kinase; tyrosine-protein kinase CAK; cell adhesion kinase; TRK E; protein-tyrosine kinase RTK 6; HGK2; CD167 antigen-like family member A (DDR1, CAK, EDDR1, NEP, NTRK4, PTK3A, RTK6, TRKE) CD168; hyaluronan mediated motility receptor; intracellular hyaluronic acid-binding protein; receptor for hyaluronan-mediated motility (HMMR, IHABP, RHAMM) CD169; sialoadhesin; sialic acid-binding Ig-like lectin 1; siglec-1 (SIGLEC1, SN) CD170; sialic acid-binding Ig-like lectin 5; siglec-5; obesity-binding protein 2; OB-binding protein 2; OB-BP2; CD33 antigen-like 2 (SIGLEC5, CD33L2, OBBP2) CD171; neural cell adhesion molecule L1; N-CAM L1 (L1CAM, CAML1, MIC5) CD172a; tyrosine-protein phosphatase non-receptor type substrate 1; SHP substrate 1; SHPS-1; brain Ig-like molecule with tyrosine-based activation motifs; Bit; CD172 antigen-like family member A; inhibitory receptor SHPS-1; macrophage fusion receptor; MyD-1 antigen; signal-regulatory protein alpha-1; Sirp-alpha-1; signal-regulatory protein alpha-2; Sirp-alpha-2; signal-regulatory protein alpha-3; Sirp-alpha-3; p84 (SIRPA, BIT, MFR, MYD1, PTPNS1, SHPS1, SIRP) CD172b; signal-regulatory protein beta-1; SIRP-beta-1; CD172 antigen-like family member B (SIRPB1) CD172g; signal-regulatory protein gamma; SIRP-gamma; CD172 antigen-like family member B; signal-regulatory protein beta-2; SIRP-b2; SIRP-beta-2 (SIRPG, SIRPB2) CD178; Fas ligand; tumor necrosis factor ligand superfamily member 6; Fas antigen ligand; CD95L protein; apoptosis antigen ligand; APTL (FASLG, APT1LG1, FASL, TNFSF6) CD179a; immunoglobulin iota chain; CD179 antigen-like family member A; protein VpreB1; V(pre)B protein; VpreB protein (VPREB1, VPREB) CD179b; immunoglobulin lambda-like polypeptide 1; CD179 antigen-like family member B; Ig lambda-5; immunoglobulin omega polypeptide; immunoglobulin-related protein 14.1 (IGLL1, IGL1) CD180 antigen; lymphocyte antigen 64; Radioprotective 105 kD protein; (CD180, LY64, RP105) CD181; high affinity interleukin-8 receptor A; IL-8R A; IL-8 receptor type 1; CXCR-1; CDw128a (IL8RA, CMKAR1, CXCR1) CD182; high affinity interleukin-8 receptor B; IL-8R B; CXCR-2; GRO/MGSA receptor; IL-8 receptor type 2; CDw128b (IL8RB, CXCR2) CD183; C-X-C chemokine receptor type 3; CXC-R3; CXCR-3; interferon-inducible protein 10 receptor; IP-10 receptor; CKR-L2; G protein-coupled receptor 9 (CXCR3, GPR9) CD184; C-X-C chemokine receptor type 4; CXC-R4; CXCR-4; stromal cell-derived factor 1 receptor; SDF-1 receptor; fusin; leukocyte-derived seven transmembrane domain receptor; LESTR; LCR1; FB22; neuropeptide Y receptor Y3; NPYRL; HM89 (CXCR4) CD185; C-X-C chemokine receptor type 5; CXC-R5; CXCR-5; Burkitt lymphoma receptor 1; monocyte-derived receptor 15; MDR-15 (CXCR5, BLR1, MDR15) CD186; C-X-C chemokine receptor type 6; CXC-R6; CXCR-6; G-protein coupled receptor bonzo; G-protein coupled receptor STRL33; CDw186 (CXCR6, BONZO, STRL33, TYMSTR) CD191; C-C chemokine receptor type 1; C-C CKR-1; CC-CKR-1; CCR-1; CCR1; macrophage inflammatory protein 1-alpha receptor; MIP-1alpha-R; RANTES-R; HM145; LD78 receptor (CCR1, CMKBR1, CMKR1, SCYAR1) CD192; C-C chemokine receptor type 2; C-C CKR-2; CC-CKR-2; CCR-2; CCR2; monocyte chemoattractant protein 1 receptor; MCP-1-R (CCR2, CMKBR2) CD193; C-C chemokine receptor type 3; C-C CKR-3; CC-CKR-3; CCR-3; CCR3; CKR3; eosinophil eotaxin receptor (CCR3, CMKBR3) CD194; C-C chemokine receptor type 4; C-C CKR-4; CC-CKR-4; CCR-4; CCR4; K5-5 (CCR4, CMKBR4) CD195; C-C chemokine receptor type 5; C-C CKR-5; CC-CKR-5; CCR-5; CCR5; HIV-1 fusion coreceptor; CHEMR13 (CCR5, CMKBR5) CD196; C-C chemokine receptor type 6; C-C CKR-6; CC-CKR-6; CCR-6; LARC receptor; GPR-CY4; GPRCY4; chemokine receptor-like 3; CKR-L3; DRY6; G-protein coupled receptor 29 (CCR6, CKRL3, CMKBR6, GPR29, STRL22) CD197; CC chemokine receptor type 7; C-C CKR-7; CC-CKR-7; CCR-7; MIP-3 beta receptor; EBV-induced G-protein coupled receptor 1; EBI1; BLR2; CDw197 (CCR7, CMKBR7, EBI1, EVI1) CDw199; C-C chemokine receptor type 9; C-C CKR-9; CC-CKR-9; CCR-9; GPR-9-6; G-protein coupled receptor 28 (CCR9, CMKBR9, GPR28) CD200; OX-2 membrane glycoprotein (CD200, MOX1, MOX2, My033) CD201; endothelial protein C receptor; activated protein C receptor; APC receptor (PROCR) CD203c; ectonucleotide pyrophosphatase/phosphodiesterase family member 3; E-NPP 3; phosphodiesterase I beta; PD-Ibeta; phosphodiesterase I/nucleotide pyrophosphatase 3; includes: alkaline phosphodiesterase I; nucleotide pyrophosphatase (ENPP3, PDNP3, NPPase) CD204 (macrophage scavenger receptor, MSR1) CD205; lymphocyte antigen 75; DEC-205; gp200-MR6 (LY75) CD206; macrophage mannose receptor 1; MMR; C-type lectin domain family 13 member D (MRC1, CLEC13D) CD207 (langerin, Langerhans cell specific C-type lectin, CLEC4K) CD208; lysosome-associated membrane glycoprotein 3; lysosomal-associated membrane protein 3; LAMP-3; DC-lysosome-associated membrane glycoprotein; DC LAMP; protein TSC403 (LAMP3, DCLAMP, TSC403) CD209; dendritic cell-specific ICAM-3-grabbing nonintegrin 1 (DC-SIGN1) CDw210a; interleukin-10 (IL-10) receptor alpha chain; IL-10R-A; IL-10R1 (IL10RA IL10R) CD212; interleukin-12 (IL-12) receptor beta-1 chain; IL-12R-beta1; interleukin-12 receptor beta; IL-12 receptor beta component; IL-12RB1 (IL12RB1, IL12R, IL12RB) CD213a1; interleukin-13 receptor alpha-1; IL-13R-alpha-1; IL-13RA-1; cancer/testis antigen 19; CT19; CD213a1 (IL13RA1, IL13R, IL13RA) CD213a2; interleukin-13 receptor alpha-2 chain; interleukin-13-binding protein (IL13RA2, IL13R) CDw217; interleukin-17 receptor A; IL-17 receptor; CD217 (IL17RA, IL17R) CDw218a; CD218a; interleukin-18 receptor 1; IL1 receptor-related protein; IL-1Rrp; CD218 antigen-like family member A (IL18R1 IL1RRP) CD218b; interleukin-18 receptor accessory protein; IL-18 receptor accessory protein; IL-18RAcP; accessory protein-like; AcPL; CD218 antigen-like family member B; CDw218b; IL-1R accessory protein-like; IL-1RAcPL; interleukin-1 receptor 7; IL-1R-7; IL-1R7; interleukin-18 receptor accessory protein-like; interleukin-18 receptor beta; IL-18R-beta; IL-18Rbeta (IL18RAP IL1R7) CD220; preproinsulin receptor; IR; contains: insulin receptor subunit alpha, insulin receptor subunit beta (INSR) CD222 (insulin-like growth factor [IGF]-2 receptor (somatomedin MSA receptor, cation-independent mannose-6-phosphate receptor, MPR 300, CI-MPR, M6PR, MPRI, IGF2R) CD223; lymphocyte activation gene 3 protein; LAG-3; FDC protein (LAG3, FDC) CD224 (gamma-glutamyltransferase-1, GGT1, gamma-glutamyltranspeptidase-1, CD224 antigen) CD225; interferon-induced transmembrane protein 1; interferon-inducible protein 9-27; interferon-induced protein 17; Leu-13 antigen (IFITM1, CD225, IFI17) CD226; DNAX accessory molecule 1; platelet & T cell activation antigen 1 (PTA1, DNAM1) CD227; mucin-1; MUC-1; polymorphic epithelial mucin; PEM; PEMT; episialin; tumor-associated mucin; carcinoma-associated mucin; tumor-associated epithelial membrane antigen; EMA; H23AG; Peanut-reactive urinary mucin; PUM; breast carcinoma-associated antigen DF3; contains: MUC1-alpha; MUC1-NT; MUC1-beta; MUC1-CT (MUC1, PUM) CD228, melanotransferrin or melanoma-associated antigen p97 CD229; T-lymphocyte surface antigen Ly-9; cell surface molecule Ly-9; lymphocyte antigen 9 (LY9) CD231; tetraspanin-7; Tspan-7; transmembrane 4 superfamily member 2; cell surface glycoprotein A15; T-cell acute lymphoblastic leukemia-associated antigen 1; TALLA-1; membrane component, X chromosome, surface marker 1 (TSPAN7, A15, DXS1692E, MXS1, TM4SF2) CD232 (plexin-C1, virus-encoded semaphorin protein receptor, PLXNC1, VESPR) CD233; band 3 anion transport protein; anion exchange protein 1; anion exchanger 1; AE 1; solute carrier family 4 member 1 (SLC4A1, AE1, DI, EPB3) CD234; Duffy antigen/chemokine receptor; Fy glycoprotein; GpFy; Glycoprotein D; plasmodium vivax receptor (DARC, FY, GPD) CD240CE; blood group Rh(CE) polypeptide; rhesus C/E antigens; Rh30A; RhIXB; Rh polypeptide 1; RhPI (RHCE, RHC, RHE) CD240D; blood group Rh(D) polypeptide; rhesus D antigen; RHXIII; Rh polypeptide 2; RhPII (RHD) CD241; ammonium transporter Rh type A; Rhesus blood group family type A glycoprotein; Rh family type A glycoprotein; Rh type A glycoprotein; Rhesus blood group-associated glycoprotein; Rhesus blood group-associated ammonia channel; erythrocyte membrane glycoprotein Rh50; erythrocyte plasma membrane 50 kD glycoprotein; Rh50A (RHAG, RH50) CD242; intercellular adhesion molecule 4; ICAM-4; Landsteiner-Wiener blood group glycoprotein; LW blood group protein (ICAM4, LW) CD244, natural killer cell receptor 2B4 (NKR2B4), NK cell type I receptor protein 2B4 (h2B4) or NK cell activation-inducing ligand (NAIL) CD246; ALK tyrosine kinase receptor; anaplastic lymphoma kinase (ALK) CD247; T-cell surface glycoprotein CD3 zeta chain; T-cell receptor T3 zeta chain (CD3Z, T3Z, TCRZ) CD248; tumor endothelial marker 1; endosialin precursor; CD248 antigen (CD164L1, TEM1) CD252; tumor necrosis factor ligand superfamily member 4; OX40 ligand; OX40L; glycoprotein Gp34; TAX transcriptionally-activated glycoprotein 1 (TNFSF4, TXGP1) CD253; tumor necrosis factor ligand superfamily member 10; apo-2 ligand; apo-2L; TNF-related apoptosis-inducing ligand; protein TRAIL (TNFSF10, APO2L, TRAIL) CD254; tumor necrosis factor ligand superfamily member 11; osteoclast differentiation factor; ODF; osteoprotegerin ligand; OPGL; receptor activator of nuclear factor kappa-B ligand; RANKL; TNF-related activation-induced cytokine; TRANCE; contains: tumor necrosis factor ligand superfamily member 11, membrane form; contains: tumor necrosis factor ligand superfamily member 11, soluble form (TNFSF11, OPGL, RANKL, TRANCE) CD257; tumor necrosis factor ligand superfamily member 13B; B lymphocyte stimulator; BLyS; B-cell-activating factor; BAFF; dendritic cell-derived TNF-like molecule; TNF- & APOL-related leukocyte expressed ligand 1; TALL-1 (TNFSF13B, BAFF, BLYS, TALL1, TNFSF20, ZTNF4, UNQ401/PRO738) CD258; tumor necrosis factor ligand superfamily member 14; Herpes virus entry mediator ligand; HVEM-L (TNFSF14, HVEML, LIGHT, UNQ391/PRO726) CD261; tumor necrosis factor receptor superfamily member 10A; death receptor 4; TNF-related apoptosis-inducing ligand receptor 1; TRAIL receptor 1; TRAIL-R1 (TNFRSF10A, APO2, DR4, TRAILR1) CD262; tumor necrosis factor receptor superfamily member 10B; death receptor 5; TNF-related apoptosis-inducing ligand receptor 2; TRAIL receptor 2; TRAIL-R2 (TNFRSF10B, DR5, KILLER, TRAILR2, TRICK2, ZTNFR9, UNQ160/PRO186) CD263; tumor necrosis factor receptor superfamily member 10C; decoy receptor 1; DcR1; Decoy TRAIL receptor without death domain; TNF-related apoptosis-inducing ligand receptor 3; TRAIL receptor 3; TRAIL-R3; trail receptor without an intracellular domain; lymphocyte inhibitor of TRAIL; antagonist decoy receptor for TRAIL/apo-2L (TNFRSF10C, DCR1, LIT, TRAILR3, TRID, UNQ321/PRO366) CD264; tumor necrosis factor receptor superfamily member 10D; decoy receptor 2; DcR2; TNF-related apoptosis-inducing ligand receptor 4; TRAIL receptor 4; TRAIL-R4; TRAIL receptor with a truncated death domain (TNFRSF10D, DCR2, TRAILR4, TRUNDD, UNQ251/PRO288) CD265; tumor necrosis factor receptor superfamily member 11A; receptor activator of NF-KB; osteoclast differentiation factor receptor; ODFR (TNFRSF11A, RANK) CD266; tumor necrosis factor receptor superfamily member 12A; fibroblast growth factor-inducible immediate-early response protein 14; FGF-inducible 14; Tweak-receptor; TweakR (TNFRSF12A, FN14) CD268; tumor necrosis factor receptor superfamily member 13C; B cell-activating factor receptor; BAFF receptor; BAFF-R; BLyS receptor 3 (TNFRSF13C, BAFFR, BR3) CD269; tumor necrosis factor receptor superfamily member 17; B-cell maturation protein (TNFRSF17, BCM, BCMA) CD271; p75 NGFR; tumor necrosis factor receptor superfamily member 16; low-affinity nerve growth factor receptor; NGF receptor; Gp80-LNGFR; p75 ICD; low affinity neurotrophin receptor p75NTR (NGFR, TNFRSF16) CD272; B- & T-lymphocyte attenuator; B- & T-lymphocyte-associated protein (BTLA) CD273 (programmed cell death 1 ligand 2, PD-L2, PD-1-ligand 2, PDCD1 ligand 2, butyrophilin B7-DC, PDCD1LG2, PDCD1L2) CD274 (programmed cell death 1 ligand 1, PD-L1, PD-1-ligand 1, PDCD1 ligand 1, B7-homolog 1, B7-H1, PDCD1LG1, PDCD1L1, PDL1) CD275; ICOS ligand; B7 homolog 2; B7-H2; B7-like protein Gl50; B7-related protein 1; B7RP-1 (ICOSLG, B7H2, B7RP1, ICOSL, KIAA0653) CD276 (costimulatory molecule, B7 homolog 3, B7-H3, 4Ig-B7-H3, B7H3, PSEC0249, UNQ309/PRO352) CD277; butyrophilin subfamily 3 member A1 (BTN3A1, BTF5) CD278; inducible T-cell co-stimulator (ICOS); activation-inducible lymphocyte immunomediatory molecule (AILIM) CD279, programmed cell death protein 1 (PDCD1, hPD-1) CD280 (macrophage mannose receptor 2, urokinase receptor-associated protein, endocytic receptor 180, MRC2, ENDO180, KIAA0709, UPARAP) CD281; Toll-like receptor 1; Toll/interleukin-1 receptor-like protein; TIL (TLR1, KIAA0012) CD282; Toll-like receptor 2; Toll/interleukin-1 receptor-like protein 4 (TLR2, TIL4) CD283 (toll like receptor 3, TLR3, CD283 antigen) CD284; Toll-like receptor 4; hToll (TLR4) CD286; Toll-like receptor 6 (TLR6) CD288; Toll-like receptor 8 (TLR8) CD289; Toll-like receptor 9 (TLR9) CD290; Toll-like receptor 10 (TLR10) CD292; bone morphogenetic protein receptor type-1A; serine/threonine protein kinase receptor R5; SKR5; activin receptor-like kinase 3; ALK-3 (BMPR1A, ACVRLK3, ALK3) CDw293; bone morphogenetic protein receptor type-1B (BMPR1B) CD295; leptin receptor; LEP-R; OB receptor; OB-R; HuB219 (LEPR, DB, OBR) CD296; GPI-linked NADP+-arginine ADP-ribosyltransferase 1; mono(ADP-ribosyl)transferase 1 (ART1) CD297; ecto-ADP-ribosyltransferase 4; Dombrock blood group carrier molecule; mono(ADP-ribosyl)transferase 4; NADP+-arginine ADP-ribosyltransferase 4 (ART4, DO, DOK1) CD298 (Na+/K+ ATPase-beta 3, ATPB-3, CD298 antigen, ATP1B3) CD299 (C-type lectin domain family 4 member M, CD209 antigen-like protein 1, dendritic cell-specific ICAM-3-grabbing nonintegrin 2, DC-SIGN2, DC-SIGN-related protein, DC-SIGNR, liver/lymph node-specific ICAM-3-grabbing nonintegrin, L-SIGN, CLEC4M, CD209L, CD209L1) CD300 family protein CD301; C-type lectin domain family 10 member A; C-type lectin superfamily member 14; macrophage lectin 2 (CLEC10A, CLECSF13, CLECSF14, HML) CD302 (C-type lectin domain family 13 member A, C-type lectin BIMLEC, type 1 transmembrane C-type lectin receptor DCL-1, CLEC13A, DCL1, KIAA0022) CD303; C-type lectin domain family 4 member C; blood dendritic cell antigen 2; BDCA-2; C-type lectin superfamily member 7; dendritic lectin (CLEC4C, BDCA2, CLECSF11, CLECSF7, DLEC, HECL, UNQ9361/PRO34150) CD304; neuropilin-1; vascular endothelial cell growth factor 165 receptor (NRP1, NRP, VEGF165R) CD305 (leukocyte-associated immunoglobulin-like receptor 1, LAIR-1, hLAIR1, LAIR1) CD306 (leukocyte-associated immunoglobulin-like receptor 2, LAIR-2, LAIR2) CD307b; Fc receptor-like protein 2; FcR-like protein 2; FcRL2; Fc receptor homolog 2; FcRH2; IFGP family protein 4; immunoglobulin receptor translocation-associated protein 4; SH2 domain-containing phosphatase anchor protein 1 (FCRL2, FCRH2, IFGP4, IRTA4, SPAP1, UNQ9236/PRO31998) CD309; vascular endothelial growth factor receptor 2; VEGFR-2; kinase insert domain receptor; protein-tyrosine kinase receptor Flk-1 (KDR, FLK1) CD312; EGF-like module-containing mucin-like hormone receptor-like 2; EGF-like module EMR2 (EMR2) CD314; NKG2-D type II integral membrane protein; NKG2-D-activating NK receptor; NK cell receptor D; killer cell lectin-like receptor subfamily K member 1 (KLRK1, D12S2489E, NKG2D) CD315; prostaglandin F2 receptor negative regulator; CD9 partner 1; CD9P-1; Glu-Trp-Ile EWI motif-containing protein F; EWI-F; prostaglandin F2-alpha receptor regulatory protein; prostaglandin F2-alpha receptor-associated protein (PTGFRN, CD9P1, EWIF, FPRP, KIAA1436) CD316 (immunoglobulin superfamily member 8, CD81 partner 3, glu-Trp-Ile EWI motif-containing protein 2, EWI-2, keratinocytes-associated transmembrane protein 4, KCT-4, LIR-D1, CD316 antigen, IGSF8, CD81P3, EWI2, KCT4) CD317; bone marrow stromal antigen 2; BST-2; tetherin; HM1.24 antigen (BST2) CD318; CUB domain-containing protein 1; membrane glycoprotein gp140; subtractive immunization M plus HEp3-associated 135 kD protein; SIMA135; transmembrane & associated with src kinases (CDCP1, TRASK, UNQ2486/PRO5773) CD319; SLAM family member 7; CD2 subset 1; CD2-like receptor-activating cytotoxic cells; CRACC; membrane protein FOAP-12; Novel Ly9; protein 19A (SLAMF7, CS1, UNQ576/PRO1138) CD320; 8D6 antigen; FDC-signaling molecule 8D6; FDC-SM-8D6; 8D6A (UNQ198/PRO224) CD321; junctional adhesion molecule A; JAM-A; junctional adhesion molecule 1; JAM-1; platelet F11 receptor; platelet adhesion molecule 1; PAM-1 (F11R, JAM1, JCAM, UNQ264/PRO301) CD322; junctional adhesion molecule B; JAM-B; junctional adhesion molecule 2; JAM-2; vascular endothelial junction-associated molecule; VE-JAM (JAM2, C21orf43, VEJAM, UNQ219/PRO245) CDw325; cadherin-2; neural cadherin; N-cadherin; CD325 (CDH2, CDHN, NCAD) CD326; epithelial cell adhesion molecule; Ep-CAM; tumor-associated Ca+2 signal transducer 1; major gastrointestinal tumor-associated protein GA733-2; epithelial cell surface antigen; epithelial glycoprotein; EGP; epithelial glycoprotein 314; EGP314; hEGP314; adenocarcinoma-associated antigen; KSA; KS 1/4 antigen; cell surface glycoprotein trop-1 (EPCAM, GA733-2, M1S2, M4S1, MIC18, TACSTD1, TROP1) CD327; sialic acid-binding Ig-like lectin 6; siglec-6; Obesity-binding protein 1; OB-BP1; CD33 antigen-like 1; CDw327 (SIGLEC6, CD33L, CD33L1, OBBP1) CD328; sialic acid-binding Ig-like lectin 7; siglec-7; QA79 membrane protein; Adhesion inhibitory receptor molecule 1; AIRM-1; p75; D-siglec; CDw328 (SIGLEC7, AIRM1) CD329; sialic acid-binding Ig-like lectin 8; siglec-8; sialoadhesin family member 2; SAF-2; CDw329 (SIGLEC8, SAF2) CD331; basic fibroblast growth factor receptor 1; FGFR-1; bFGF-R; Fms-like tyrosine kinase 2; c-fgr; (FGFR1, FGFBR, FLG, FLT2) CD332; fibroblast growth factor receptor 2; FGFR-2; keratinocyte growth factor receptor 2 (FGFR2, BEK, KGFR, KSAM) CD333; fibroblast growth factor receptor 3; FGFR-3 (FGFR3, JTK4) CD334; fibroblast growth factor receptor 4; FGFR-4 (FGFR4, JTK2, TKF) CD335; natural cytotoxicity triggering receptor 1; lymphocyte antigen 94 homolog; NK cell-activating receptor; natural killer cell p46-related protein; NK-p46; NKp46; hNKp46 (NCR1, LY94) CD336; natural cytotoxicity triggering receptor 2; lymphocyte antigen 95 homolog; NK cell-activating receptor; natural killer cell p44-related protein; NK-p44; NKp44 (NCR2, LY95) CD337; natural cytotoxicity triggering receptor 3; activating natural killer receptor p30; natural killer cell p30-related protein; NK-p30; NKp30 (NCR3, 1C7, LY117) CD338; CDw338; ATP-binding cassette sub-family G member 2; placenta-specific ATP-binding cassette transporter; breast cancer resistance protein; mitoxantrone resistance-associated protein (ABCG2, ABCP, BCRP, BCRP1, MXR) CD339; protein jagged-1; Jagged1; hJ1 (JAG1, JAGL1) CD340; receptor tyrosine-protein kinase erbB-2; p185erbB2; C-erbB-2; NEU proto-oncogene; tyrosine kinase-type cell surface receptor HER2; MLN 19 (ERBB2, HER2, NEU, NGL) CD344; frizzled-4; Fz-4; hFz4; FzE4 (FZD4) CD349; frizzled-9; Fz-9; hFz9; FzE6 (FZD9 FZD3) CD350; frizzled-10; Fz-10; hFz10; FzE7 (FZD10) CD355; cytotoxic & regulatory T-cell molecule; class-I MHC-restricted T-cell-associated molecule (CRTAM) tumor necrosis factor ligand superfamily member 13B; B lymphocyte stimulator; BLyS; B-cell-activating factor; BAFF; dendritic cell-derived TNF-like molecule; TNF- & APOL-related leukocyte expressed ligand 1; TALL-1; CD257 (TNFSF13B, BAFF, BLYS, TALL1, TNFSF20, ZTNF4, UNQ401/PRO738)

General

cell surface antigen plasma membrane protein

Properties

COMPARTMENT: plasma membrane MOTIF: glycosylation site membrane region